Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gitomer

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Contemporary Clinical Trials Communications|December 9, 2020
Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participantsKristen L Nowak, Heather Farmer-Bailey, Melissa A Cadnapaphornchai, et al.
JAMA Network Open|October 18, 2022
Association Between Electronic Health Record Time and Quality of Care Metrics in Primary CareLisa S Rotenstein, A Jay Holmgren, Michael J Healey, et al.
Journal of Materials Chemistry. B|August 19, 2014
Development of Superoxide Dismutase Mimetic Surfaces to Reduce Accumulation of Reactive Oxygen Species for Neural Interfacing ApplicationsKelsey A Potter-Baker, Jessica K Nguyen, Kyle M Kovach, et al.
Kidney360|December 11, 2020
Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney DiseaseLaura Grau, Berenice Gitomer, Bryan McNair, et al.
Journal of Lipid Research|December 18, 2013
Bioactive lipid mediators in polycystic kidney diseaseJelena Klawitter, Jost Klawitter, Kim McFann, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Giant cell tubulitis with tubular basement membrane immune deposits: a report of two cases after cardiac valve replacement surgeryAnthony Chang, Carine J Peutz-Kootstra, Jolanta Kowalewska, et al.
Cell Reports. Medicine|June 3, 2026
Type I interferon signaling in hematopoietic cells impairs neutrophil antibacterial function in the middle ear during viral co-infectionSteven C Shaw, Taylor L Jamil, Gabriela Heslop, et al.
Kidney International Reports|November 17, 2017
A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney DiseaseRonald D Perrone, Mohamad-Samer Mouksassi, Klaus Romero, et al.
Clinical Kidney Journal|April 10, 2025
Time-restricted eating and autosomal dominant polycystic kidney disease: a pilot, randomized clinical trialCortney Steele, Anna Ostrow, Wei Wang, et al.
Kidney International Reports|November 17, 2017
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney DiseaseRonald D Perrone, Mohamad-Samer Mouksassi, Klaus Romero, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Contemporary Clinical Trials Communications|December 9, 2020
Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participantsKristen L Nowak, Heather Farmer-Bailey, Melissa A Cadnapaphornchai, et al.
JAMA Network Open|October 18, 2022
Association Between Electronic Health Record Time and Quality of Care Metrics in Primary CareLisa S Rotenstein, A Jay Holmgren, Michael J Healey, et al.
Journal of Materials Chemistry. B|August 19, 2014
Development of Superoxide Dismutase Mimetic Surfaces to Reduce Accumulation of Reactive Oxygen Species for Neural Interfacing ApplicationsKelsey A Potter-Baker, Jessica K Nguyen, Kyle M Kovach, et al.
Kidney360|December 11, 2020
Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney DiseaseLaura Grau, Berenice Gitomer, Bryan McNair, et al.
Journal of Lipid Research|December 18, 2013
Bioactive lipid mediators in polycystic kidney diseaseJelena Klawitter, Jost Klawitter, Kim McFann, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Giant cell tubulitis with tubular basement membrane immune deposits: a report of two cases after cardiac valve replacement surgeryAnthony Chang, Carine J Peutz-Kootstra, Jolanta Kowalewska, et al.
Cell Reports. Medicine|June 3, 2026
Type I interferon signaling in hematopoietic cells impairs neutrophil antibacterial function in the middle ear during viral co-infectionSteven C Shaw, Taylor L Jamil, Gabriela Heslop, et al.
Kidney International Reports|November 17, 2017
A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney DiseaseRonald D Perrone, Mohamad-Samer Mouksassi, Klaus Romero, et al.
Clinical Kidney Journal|April 10, 2025
Time-restricted eating and autosomal dominant polycystic kidney disease: a pilot, randomized clinical trialCortney Steele, Anna Ostrow, Wei Wang, et al.
Kidney International Reports|November 17, 2017
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney DiseaseRonald D Perrone, Mohamad-Samer Mouksassi, Klaus Romero, et al.
Pageof 18